Market Closed

AVTX
Avalo Therapeutics
$ 7.76
0.78%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Avalo Therapeutics News

Latest Avalo Therapeutics Stock News & AVTX Headlines

Here's Why Avalo Therapeutics (AVTX) is Poised for a Turnaround After Losing 40.4% in 4 Weeks
4 days ago | zacks.com
Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates
11 days ago | globenewswire.com
Avalo Therapeutics to Participate in Upcoming Investor Conferences
13 days ago | globenewswire.com
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3
22 days ago | seekingalpha.com
This Avalo Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
24 days ago | benzinga.com
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
2 months ago | globenewswire.com
Christopher Ryan Sullivan Sells 12,394 Shares of Avalo Therapeutics (NASDAQ:AVTX) Stock
2 months ago | defenseworld.net
Avalo Therapeutics to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
3 months ago | globenewswire.com
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

AVTX
Avalo Therapeutics
$ 7.76
0.78%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago